Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : February 8, 2016 4:26 PM IST
A common cholesterol-lowering drug statin can restore vision in the patients with a hard-to-treat version of the leading cause of blindness in the developed world, according to a new research. Researchers at Massachusetts Eye and Ear/Harvard Medical School and the University of Crete have conducted a phase I/II clinical trial investigating the efficacy of statins in the treatment of patients with the dry form of age-related macular degeneration (AMD). Read: Statins does this cholesterol-lowering drug have any side-effects?
The researchers found evidence that treatment with high-dose atorvastatin (80mg) is associated with regression of lipid deposits and improvement in visual acuity, without progression to advanced disease, in high-risk AMD patients. Their findings not only further the connection between lipids, AMD and atherosclerosis but also present a potential therapy for some patients with dry AMD. Read: Cholesterol-lowering drug can treat Parkinson s, says a new study
Researcher Joan W. Miller said that they found that concentrated doses of statins carry the potential for clearing up the lipid debris that can lead to vision impairment in a subset of patients with macular degeneration. Miller added that the researchers hope that this promising preliminary clinical trial will be the foundation for an effective treatment for millions of patients afflicted with AMD. The study is published in EBioMedicine. Read: Cholesterol-lowering drug likely to trigger anger in women
Source: ANI
Image Source: Getty Images
